Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of the fiscal period ended Wednesday, December 31, 2025.
Reported annual fiscal-period values; no daily interpolation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
-0.96x
EV/EBIT RATIO AVG 3Y
-3.14x
EV/EBIT RATIO AVG 5Y
-3.29x
EV/EBIT RATIO AVG 10Y
-3.50x
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
PDS Biotechnology Corporation
Market Cap
$11.79M
EV/EBIT Ratio
N/A
TTM Avg
-0.96x
3Y Avg
-3.14x
5Y Avg
-3.29x
Market Cap
$438.82M
EV/EBIT Ratio
N/A
TTM Avg
-15.91x
3Y Avg
-20.06x
5Y Avg
-20.06x
Market Cap
$1.18B
EV/EBIT Ratio
N/A
TTM Avg
-3.74x
3Y Avg
-5.94x
5Y Avg
-19.44x
Market Cap
$2.23B
EV/EBIT Ratio
10.10x
TTM Avg
18.30x
3Y Avg
18.30x
5Y Avg
20.20x
Market Cap
$3.06B
EV/EBIT Ratio
48.95x
TTM Avg
48.47x
3Y Avg
65.37x
5Y Avg
65.37x
Market Cap
$5.40B
EV/EBIT Ratio
28.81x
TTM Avg
27.98x
3Y Avg
35.25x
5Y Avg
45.79x
Market Cap
$6.43B
EV/EBIT Ratio
259.98x
TTM Avg
122.21x
3Y Avg
156.68x
5Y Avg
156.68x
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PDS Biotechnology Corporation (PDSB) | $11.79M | N/A | -0.96x | -3.14x | -3.29x |
| Shoulder Innovations, Inc. (SI)vs › | $438.82M | N/A | -15.91x | -20.06x | -20.06x |
| NRC Health (NRC)vs › | $492.43M | 38.52x | 20.63x | 18.36x | 19.65x |
| Teladoc Health, Inc. (TDOC)vs › | $1.18B | N/A | -3.74x | -5.94x | -19.44x |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $2.23B | 10.10x | 18.30x | 18.30x | 20.20x |
| TransMedics Group, Inc. (TMDX)vs › | $3.06B | 48.95x | 48.47x | 65.37x | 65.37x |
| Doximity, Inc. (DOCS)vs › | $5.00B | 24.97x | 31.33x | 39.57x | 58.76x |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.40B | 28.81x | 27.98x | 35.25x | 45.79x |
| Hims & Hers Health, Inc. (HIMS)vs › | $6.43B | 259.98x | 122.21x | 156.68x | 156.68x |
| Chemed Corporation (CHE)vs › | $6.84B | 20.95x | 18.45x | 22.35x | 22.20x |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2025-12-31 | -0.82x |
| 2024-12-31 | -1.09x |
| 2023-12-31 | -2.81x |
| 2022-12-31 | -7.85x |
| 2021-12-31 | -6.65x |
| 2020-12-31 | -0.51x |
| 2019-12-31 | -0.05x |
| 2018-12-31 | 0.78x |
| 2017-12-31 | -4.18x |
| 2016-12-31 | -6.82x |
| 2015-12-31 | -8.52x |
| 2014-12-31 | -11.77x |
| 2013-12-31 | -24.40x |
| 2012-12-31 | -35.46x |
